Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Clinical trial NCT02115542 · COMPLETED
Trial details
- NCT number
- NCT02115542
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-05
- Primary completion
- 2018-12-10
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.